MiR-431 inhibits cell proliferation and induces cell apoptosis by targeting CDK14 in pancreatic cancer

被引:2
|
作者
Yang, J. [1 ]
Zhu, H. [1 ]
Jin, Y. [1 ]
Song, Y. [1 ]
机构
[1] First Peoples Hosp Wujiang Dist Suzhou, Dept Gastroenterol, Suzhou, Peoples R China
关键词
MiRNA-431; Pancreatic cancer; Proliferation; Apoptosis; HEPATOCELLULAR-CARCINOMA CELLS; BREAST-CANCER; DIAGNOSTIC-VALUE; DOWN-REGULATION; INVASION; EXPRESSION; MIGRATION; MICRORNA-431; PROGNOSIS; TISSUE;
D O I
暂无
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
OBJECTIVE: To investigate the role of miR-431 in the proliferation and apoptosis of pancreatic cancer cells. MATERIALS AND METHODS: The pancreatic cancer cell was used for in vitro experiments. Quantitative reverse transcriptase-polymerase chain reaction (qRT-PCR) method was used to confirm the level of miR-431. Cell Counting Kit-8 (CCK-8) was used to detect the effect of miR-431 on cell proliferation. Flow cytometry was used to evaluate cell apoptosis rate and the changes of cell cycle arrest. The luciferase reporter assay was used to confirm the regulatory mechanism. RESULTS: MiR-431 expression was reduced both in cancer tissues and cell lines. Cell proliferative ability was effectively lessened after up-regulating miR-431. Elevated miR-431 significantly induced cell apoptosis and modulated cell cycle arrest. Meanwhile, CDK14 (cyclin-dependent kinase 14) was a target gene of miR-431, and over-expression of miR-431 decreased the level of CDK14. CONCLUSIONS: MiR-431 inhibits cell proliferation and induces cell apoptosis by targeting CDK14 in pancreatic cancer.
引用
收藏
页码:4493 / 4499
页数:7
相关论文
共 50 条
  • [1] miR-455 inhibits breast cancer cell proliferation through targeting CDK14
    Wang, Bing
    Zou, Aimei
    Ma, Liqiang
    Chen, Xiong
    Wang, Lie
    Zeng, Ximing
    Tan, Ting
    EUROPEAN JOURNAL OF PHARMACOLOGY, 2017, 807 : 138 - 143
  • [2] miR-216a inhibits osteosarcoma cell proliferation, invasion and metastasis by targeting CDK14
    Quanbo Ji
    Xiaojie Xu
    Ling Li
    Stuart B Goodman
    Wenzhi Bi
    Meng Xu
    Yameng Xu
    Zhongyi Fan
    William J Maloney
    Qinong Ye
    Yan Wang
    Cell Death & Disease, 2017, 8 : e3103 - e3103
  • [3] miR-216a inhibits osteosarcoma cell proliferation, invasion and metastasis by targeting CDK14
    Ji, Quanbo
    Xu, Xiaojie
    Li, Ling
    Goodman, Stuart B.
    Bi, Wenzhi
    Xu, Meng
    Xu, Yameng
    Fan, Zhongyi
    Maloney, William J.
    Ye, Qinong
    Wang, Yan
    CELL DEATH & DISEASE, 2017, 8 : e3103 - e3103
  • [4] miR-1-3p Inhibits Osteosarcoma Cell Proliferation and Cell Cycle Progression While Promoting Cell Apoptosis by Targeting CDK14 to Inactivate Wnt/Beta-Catenin Signaling
    Zhang, Guangheng
    Guan, Qingyu
    Zhao, Yingsong
    Wang, Siyuan
    Li, Hewei
    MOLECULAR BIOTECHNOLOGY, 2024, 66 (07) : 1497 - +
  • [5] MiR-542-3p, a microRNA targeting CDK14, suppresses cell proliferation, invasiveness, and tumorigenesis of epithelial ovarian cancer
    Li, Jingwei
    Shao, Wei
    Feng, Huian
    BIOMEDICINE & PHARMACOTHERAPY, 2019, 110 : 850 - 856
  • [6] Over-expression of miR-1271 inhibits endometrial cancer cells proliferation and induces cell apoptosis by targeting CDK1
    Li, L.
    Qu, Y. -W.
    Li, Y. -P.
    EUROPEAN REVIEW FOR MEDICAL AND PHARMACOLOGICAL SCIENCES, 2017, 21 (12) : 2816 - 2822
  • [7] MicroRNA-874 inhibits cell proliferation and induces apoptosis in human breast cancer by targeting CDK9
    Wang, Ling
    Gao, Wen
    Hu, Fan
    Xu, Zhiyang
    Wang, Fuqiang
    FEBS LETTERS, 2014, 588 (24) : 4527 - 4535
  • [8] miR-7 inhibits colorectal cancer cell proliferation and induces apoptosis by targeting XRCC2
    Xu, Kaiwu
    Chen, Zhihui
    Qin, Changjiang
    Song, Xinming
    ONCOTARGETS AND THERAPY, 2014, 7 : 325 - 332
  • [9] miR-98 inhibits cell proliferation and induces cell apoptosis by targeting MAPK6 in HUVECs
    Hu, Chuanxian
    Huang, Su
    Wu, Fafu
    Ding, Hui
    EXPERIMENTAL AND THERAPEUTIC MEDICINE, 2018, 15 (03) : 2755 - 2760
  • [10] MiR-128-1-5p inhibits cell proliferation and induces cell apoptosis via targeting PRKCQ in colorectal cancer
    Jia, Qingan
    Liao, Xia
    Xu, Binghui
    Li, Yufang
    Liang, Lei
    CANCER BIOLOGY & THERAPY, 2023, 24 (01)